{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:52:42Z","timestamp":1776855162490,"version":"3.51.2"},"reference-count":97,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.lpm.2007.02.015","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T05:23:55Z","timestamp":1201325035000},"page":"860-874","source":"Crossref","is-referenced-by-count":22,"special_numbering":"P2","title":["Granulomatose de\u00a0Wegener"],"prefix":"10.1016","volume":"36","author":[{"given":"Christian","family":"Pagnoux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2007.02.015_bib1","first-page":"533","article-title":"Wegener's granulomatosis: pathology and review of the literature","volume":"58","author":"Godman","year":"1954","journal-title":"AMA Arch Pathol"},{"key":"10.1016\/j.lpm.2007.02.015_bib2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib4","first-page":"427","article-title":"Wegener\u2019s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee","volume":"83","author":"Anderson","year":"1992","journal-title":"QJM"},{"key":"10.1016\/j.lpm.2007.02.015_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener\u2019s granulomatosis: long-term outcome in 155 patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib7","first-page":"261","article-title":"Wegener's granulomatosis: histological documentation of common and uncommon manifestations in 216 patients","volume":"26","author":"Lie","year":"1997","journal-title":"Vasa"},{"key":"10.1016\/j.lpm.2007.02.015_bib8","first-page":"2265","article-title":"Giant-cell granuloma of the respiratory tract (Wegener\u2019s granulomatosis)","author":"Walton","year":"1958","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2007.02.015_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archneur.58.8.1215","article-title":"Standardized neurologic evaluations of 128 patients with Wegener granulomatosis","volume":"58","author":"de Groot","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2007.02.015_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.410330103","article-title":"Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic","volume":"33","author":"Nishino","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2007.02.015_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ndt\/15.5.611","article-title":"Wegener\u2019s granulomatosis: clinical course in 108 patients with renal involvement","volume":"15","author":"Aasarod","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2007.02.015_bib12","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener\u2019s granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9343(96)80066-0","article-title":"Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener\u2019s Granulomatosis Classification Criteria Cohort","volume":"101","author":"Matteson","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780390112","article-title":"The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources","volume":"39","author":"Cotch","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib15","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4065\/80.11.1435","article-title":"Echocardiographic findings in patients with Wegener granulomatosis","volume":"80","author":"Oliveira","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.lpm.2007.02.015_bib16","first-page":"309","article-title":"Wegener\u2019s granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s","volume":"29","author":"Abdou","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2007.02.015_bib17","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E","article-title":"A staged approach to the treatment of Wegener\u2019s granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance","volume":"42","author":"Langford","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01450893","article-title":"Primary vasculitis in a Norwegian community hospital: a retrospective study","volume":"17","author":"Haugeberg","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2007.02.015_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.berh.2004.11.006","article-title":"What is known about the epidemiology of the vasculitides?","volume":"19","author":"Watts","year":"2005","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.lpm.2007.02.015_bib21","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6","article-title":"Epidemiology of Wegener\u2019s granulomatosis in northern Norway","volume":"43","author":"Koldingsnes","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.20928","article-title":"Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register","volume":"53","author":"Reinhold-Keller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/art.10830","article-title":"Are environmental factors important in primary systemic vasculitis? A case-control study","volume":"48","author":"Lane","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ki.1993.186","article-title":"Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis","volume":"43","author":"Esnault","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.02.015_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.autrev.2004.06.003","article-title":"Complex genetics of Wegener granulomatosis","volume":"4","author":"Jagiello","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2007.02.015_bib26","first-page":"196","article-title":"HLA genes in ANCA-associated vasculitides","volume":"14","author":"Griffith","year":"1997","journal-title":"Exp Clin Immunogenet"},{"key":"10.1016\/j.lpm.2007.02.015_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.ASN.0000040751.83734.D1","article-title":"Membrane expression of proteinase 3 is genetically determined","volume":"14","author":"Schreiber","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.02.015_bib28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00439-004-1092-z","article-title":"New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes","volume":"114","author":"Jagiello","year":"2004","journal-title":"Hum Genet"},{"key":"10.1016\/j.lpm.2007.02.015_bib29","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1002\/art.21487","article-title":"The PTPN22 620W allele is a risk factor for Wegener's granulomatosis","volume":"52","author":"Jagiello","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib30","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.20385","article-title":"An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis","volume":"50","author":"Zhou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib32","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lpm.2007.02.015_bib33","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/art.21773","article-title":"Mediation of endothelial cell damage by serine proteases, but not superoxide, released from antineutrophil cytoplasmic antibody-stimulated neutrophils","volume":"54","author":"Lu","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib34","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","article-title":"Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo","volume":"104","author":"Pfister","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2007.02.015_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","article-title":"Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3","volume":"10","author":"Pendergraft","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ard.62.2.162","article-title":"Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa","volume":"62","author":"Filer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2007.02.015_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/ard.2005.040980","article-title":"Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis","volume":"65","author":"Woywodt","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2007.02.015_bib38","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1523-1755.2004.00853.x","article-title":"Wegener\u2019s granulomatosis is associated with organ-specific antiendothelial cell antibodies","volume":"66","author":"Holmen","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.02.015_bib39","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","article-title":"Cytokine profiles in Wegener\u2019s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation","volume":"42","author":"Csernok","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/thorax.56.10.751","article-title":"CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener\u2019s granulomatosis","volume":"56","author":"Lamprecht","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2007.02.015_bib41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2249.2001.01575.x","article-title":"Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener\u2019s granulomatosis","volume":"126","author":"Steiner","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.lpm.2007.02.015_bib42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaut.2005.08.004","article-title":"BAFF is elevated in serum of patients with Wegener\u2019s granulomatosis","volume":"25","author":"Krumbholz","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lpm.2007.02.015_bib43","first-page":"105112","article-title":"Is PR3-ANCA Formation Initiated in Wegener\u2019s Granulomatosis Lesions? Granulomas as Potential Lymphoid Tissue Maintaining Autoantibody Production","author":"Voswinkel","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.lpm.2007.02.015_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1189\/jlb.0905526","article-title":"Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes","volume":"79","author":"Megiovanni","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.lpm.2007.02.015_bib45","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood-2005-05-1875","article-title":"Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway","volume":"107","author":"Csernok","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2007.02.015_bib46","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/art.21669","article-title":"Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis","volume":"54","author":"van Rossum","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib47","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/ard.2003.017954","article-title":"Expression of matrix metalloproteinases in patients with Wegener\u2019s granulomatosis","volume":"63","author":"Bjerkeli","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2007.02.015_bib48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00000478-199006000-00006","article-title":"Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients","volume":"14","author":"Devaney","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2007.02.015_bib49","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/00005537-200308000-00008","article-title":"Subglottic stenosis associated with Wegener\u2019s granulomatosis","volume":"113","author":"Gluth","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.lpm.2007.02.015_bib50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.md.0000200166.90373.41","article-title":"Central nervous system involvement in Wegener granulomatosis","volume":"85","author":"Seror","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2007.02.015_bib51","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1212\/WNL.43.7.1334","article-title":"The spectrum of neurologic involvement in Wegener's granulomatosis","volume":"43","author":"Nishino","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2007.02.015_bib52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archderm.1994.01690070055008","article-title":"Wegener's granulomatosis. Dermatological manifestations in 75 cases with clinicopathologic correlation","volume":"130","author":"Franc\u00e8s","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2007.02.015_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00000478-199502000-00005","article-title":"Cutaneous pathology in Wegener's granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients","volume":"19","author":"Barksdale","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2007.02.015_bib54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0049-0172(80)90005-0","article-title":"Cardiac complications of Wegener granulomatosis: a case report of complete heart block and review of the literature","volume":"10","author":"Forstot","year":"1980","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/rheumatology\/37.4.387","article-title":"Severe intestinal involvement in Wegener\u2019s granulomatosis: report of two cases and review of the literature","volume":"37","author":"Storesund","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2007.02.015_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","volume":"84","author":"Pagnoux","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2007.02.015_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/rheumatology\/37.3.331","article-title":"Relapse of Wegener\u2019s granulomatosis in the first trimester of pregnancy: a case report","volume":"37","author":"Kumar","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2007.02.015_bib58","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/ard.59.10.800","article-title":"Pregnancy in patients with Wegener's granulomatosis: report of five cases in three women","volume":"59","author":"Auzary","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2007.02.015_bib59","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","article-title":"Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study","volume":"142","author":"Merkel","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib60","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/01.CIR.102.13.1470","article-title":"Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?","volume":"102","author":"Raza","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2007.02.015_bib61","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.11075","article-title":"Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial","volume":"48","author":"Stone","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-111-1-28","article-title":"Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis","volume":"111","author":"Nolle","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0887-8994(98)00071-X","article-title":"Pediatric Wegener's granulomatosis complicated by central nervous system vasculitis","volume":"19","author":"von Scheven","year":"1998","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.lpm.2007.02.015_bib64","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00129492-200409000-00030","article-title":"Hearing loss in Wegener's granulomatosis","volume":"25","author":"Bakthavachalam","year":"2004","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.lpm.2007.02.015_bib65","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.55.5.636","article-title":"Superficial peroneal nerve\/peroneus brevis muscle biopsy in vasculitic neuropathy","volume":"55","author":"Collins","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2007.02.015_bib66","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1056\/NEJM200311203492116","article-title":"Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Sanders","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib67","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/art.21117","article-title":"Damage caused by Wegener\u2019s granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)","volume":"52","author":"Seo","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/art.20082","article-title":"Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients","volume":"51","author":"Bligny","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib69","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1097\/01.ASN.0000093256.18266.22","article-title":"High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement","volume":"14","author":"Westman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.02.015_bib70","first-page":"80","article-title":"Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis","volume":"30","author":"Koldingsnes","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2007.02.015_bib71","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","article-title":"Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis","volume":"143","author":"Hogan","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib72","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9343(99)00064-9","article-title":"Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis","volume":"106","author":"Kyndt","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib73","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/art.20234","article-title":"Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis","volume":"51","author":"Slot","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib74","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/ndt\/17.12.2077","article-title":"Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis","volume":"17","author":"Stegeman","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2007.02.015_bib75","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener\u2019s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib76","first-page":"2167","article-title":"Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis","volume":"32","author":"Lurati-Ruiz","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2007.02.015_bib77","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0140-6736(90)92205-V","article-title":"Prevention of relapses in Wegener\u2019s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre","volume":"336","author":"Tervaert","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.02.015_bib78","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.berh.2004.11.004","article-title":"How to induce remission in primary systemic vasculitis","volume":"19","author":"Jayne","year":"2005","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.lpm.2007.02.015_bib79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-129-1-199807010-00012","article-title":"Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity","volume":"129","author":"Langford","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib81","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9343(03)00077-9","article-title":"Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener\u2019s granulomatosis: extended follow-up and rate of relapse","volume":"114","author":"Langford","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib82","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","article-title":"Mycophenolate mofetil for maintenance therapy of Wegener\u2019s granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement","volume":"10","author":"Nowack","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.02.015_bib83","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.20240","article-title":"Mycophenolate mofetil for remission maintenance in the treatment of Wegener\u2019s granulomatosis","volume":"51","author":"Langford","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib84","doi-asserted-by":"crossref","first-page":"c100","DOI":"10.1159\/000089667","article-title":"Mycophenolate Mofetil in Anti-Neutrophil Cytoplasm Antibodies-Associated Systemic Vasculitis","volume":"102","author":"Koukoulaki","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.lpm.2007.02.015_bib85","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/art.1780391215","article-title":"Therapy for the maintenance of remission in sixty-five patients with generalized Wegener\u2019s granulomatosis. Methotrexate versus trimethoprim\/sulfamethoxazole","volume":"39","author":"de Groot","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib86","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener\u2019s granulomatosis. Dutch Co-Trimoxazole Wegener Study Group","volume":"335","author":"Stegeman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib87","first-page":"249","article-title":"Immunosuppressive therapy is always required for the treatment of limited Wegener's granulomatosis","volume":"13","author":"Hoffman","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.lpm.2007.02.015_bib88","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.1780351113","article-title":"The treatment of Wegener\u2019s granulomatosis with glucocorticoids and methotrexate","volume":"35","author":"Hoffman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib89","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.02.015_bib90","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","article-title":"Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity","volume":"93","author":"Jayne","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.lpm.2007.02.015_bib91","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1526-0968.2003.00036.x","article-title":"Indications of plasma exchanges for systemic vasculitides","volume":"7","author":"Guillevin","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.lpm.2007.02.015_bib92","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNF-\u03b1 blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.02.015_bib93","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-\u03b1 antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2007.02.015_bib94","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib95","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/rheumatology\/kel098","article-title":"Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab","volume":"45","author":"Stasi","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2007.02.015_bib96","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for Refractory Wegener's Granulomatosis: Report of A Prospective, Open-Label Pilot Trial","volume":"173","author":"Keogh","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2007.02.015_bib97","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","article-title":"Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients","volume":"65","author":"Schmitt","year":"2004","journal-title":"Kidney Int"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207001777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207001777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:52:02Z","timestamp":1630608722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498207001777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":97,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0755498207001777"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2007.02.015","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}